Cerliponase Alfa May Slow Symptoms of CLN2 Disease in Children Cerliponase Alfa May Slow Symptoms of CLN2 Disease in Children

Enzyme-replacement therapy with intraventricular cerliponase alfa may delay motor and language declines in ceroid lipofuscinosis type 2 (CLN2) disease, a fatal neurodegenerative disorder.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news